NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/21/2022
Back to search
Official data from USPTO
IMMUNOBANK
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
10/17/2022
Trademark type
Word
Nice classes
44
Filing date
11/05/2020
Registration date
06/21/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/21/2022
Last transaction
10/17/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/30/2021
First use in commerce
11/30/2021
Drawing code
4
Owner type
03
Owner location
La Jolla, CA
Examiner
OH, WON TEAK
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Atherovax Inc.
Representatives
Atherovax Inc.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Isolationcollectionbanking of biological samples from healthy donors and patients with immune diseasesincludingbut not limited toallergiesinfectionsautoimmune diseasescanceratherosclerosis
Publications
History of USPTO decisions and trademark events.
36 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/21/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/19/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/18/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/28/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/28/2022
ALIE
ASSIGNED TO LIE
04/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/20/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/21/2022
GNRT
NON-FINAL ACTION E-MAILED
01/21/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
01/21/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/26/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/26/2021
IUAF
USE AMENDMENT FILED
12/01/2021
EISU
TEAS STATEMENT OF USE RECEIVED
12/01/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/05/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/10/2021
PUBO
PUBLISHED FOR OPPOSITION
08/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/21/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/01/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
07/01/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/01/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
07/01/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/01/2021
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/01/2021
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/22/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/10/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
05/24/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/24/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
05/24/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/24/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/19/2021
GNRT
NON-FINAL ACTION E-MAILED
04/19/2021
CNRT
NON-FINAL ACTION WRITTEN
04/19/2021
DOCK
ASSIGNED TO EXAMINER
04/12/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2021
Continuous trademark protection
Get notified about every new filing that threatens IMMUNOBANK or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.